Patent directory · USPTO A61K / A61P
Patents matching “insulin”
91 pharma patents match "insulin" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 91 pharmaceutical patents matching "insulin" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10570185
Method to detect autoantibody reactivity for deamidated insulin autoantigen in diabetes
granted -
US 10548850
Therapeutic composition comprising insulin prepared for delivery into an intestinal tract
granted -
US 10494632
Insulin-like growth factor binding protein, acid labile subunit (IGFALS) compositions and methods of use thereof
granted -
US 10406210
High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
granted -
US 10363288
Insulin mimotopes and methods of using the same
granted -
US 10322168
High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
granted -
US 10258573
Micronized insulin and micronized insulin analogues prepared under acidic conditions, and methods of manufacturing the same under acidic conditions
granted -
US 10188739
Compositions and methods for administering insulin or insulin-like protein to the brain
granted -
US 10105414
Peptides derived from RS1 which down-regulate glucose absorption after a glucose rich meal and increase insulin sensitivity
granted -
US 9956178
Methods for delivering insulin preparations into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 9801938
Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists
granted -
US 9676846
Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
granted -
US 9657096
Human domain antibodies against components of the human insulin-like growth factor (IGF) system
granted -
US 9623055
Method for preventing and/or treating insulin resistance
granted -
US 9624472
Production of insulin producing cells
granted -
US 9592265
Modulation of oxidative stress, inflammation, and impaired insulin sensitivity with grape seed extract
granted -
US 9457065
Methods for delivering insulin preparations into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 9433650
Method for preventing and/or treating insulin resistance
granted -
US 9150644
Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
granted -
US 9127056
Monospecific and bispecific human monoclonal antibodies targeting insulin-like growth factor II (IGF-II)
granted -
US 9101601
Methods of treating or preventing insulin resistance and associated diseases and conditions
granted -
US 9085757
Production of insulin producing cells
granted -
US 9056907
Human domain antibodies against components of the human insulin-like growth factor (IGF) system
granted -
US 8993633
Treatment of muscle disease characterized by insulin resistance
granted